Lung cancer (NSCLC) (Tissue) 2021 and PIK3CA testing in breast cancer.
selected by EMQN to be used as educational examples of good reporting practice for member access on their website.
making GenoMed® a successful company!
Search for Gene or Disease
a DNA, a PERSON, a TEST
GenoMed® makes the difference through establishing a doctor/laboratory proximity relationship, working together to select the most appropriate test for each patient. Our main objective is to facilitate diagnoses and personalised therapeutic options, from a molecular point of view, for a wide range of diseases, including rare, cardiovascular, or oncological diseases.
We acknowledge the importance of following scientific and technological developments in order to accomplish Precision Medicine. Thus, we work in an Open Innovation format, being able to analyse any gene, regardless of the rarity of the associated disease. At the same time, we are always available to create new panels or customize existing panels, making them individual and specific, even for more complex cases.